Gerald Preston

Array ( [id] => 2766833 [patent_doc_number] => 05035994 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-07-30 [patent_title] => 'Human stem cells and monoclonal antibodies' [patent_app_type] => 1 [patent_app_number] => 7/580337 [patent_app_country] => US [patent_app_date] => 1990-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9823 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/035/05035994.pdf [firstpage_image] =>[orig_patent_app_number] => 580337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2978554 [patent_doc_number] => 05256768 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-26 [patent_title] => 'Expression of antigenic Epstein-Barr virus polypeptides in bacteria and their use in diagnostics' [patent_app_type] => 1 [patent_app_number] => 7/578480 [patent_app_country] => US [patent_app_date] => 1990-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 5926 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/256/05256768.pdf [firstpage_image] =>[orig_patent_app_number] => 578480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2784924 [patent_doc_number] => 05130297 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-07-14 [patent_title] => 'Conjugates useful in ameliorating autoimmunity MHC-II-peptide' [patent_app_type] => 1 [patent_app_number] => 7/576084 [patent_app_country] => US [patent_app_date] => 1990-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 7 [patent_no_of_words] => 8192 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/130/05130297.pdf [firstpage_image] =>[orig_patent_app_number] => 576084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2885292 [patent_doc_number] => 05109112 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-04-28 [patent_title] => 'FK-506 cytosolic binding protein' [patent_app_type] => 1 [patent_app_number] => 7/548429 [patent_app_country] => US [patent_app_date] => 1990-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 5625 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/109/05109112.pdf [firstpage_image] =>[orig_patent_app_number] => 548429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2754237 [patent_doc_number] => 05071962 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-12-10 [patent_title] => 'Nucleotide, deduced amino acid sequence, isolation and purification of heat-shock chlamydial proteins' [patent_app_type] => 1 [patent_app_number] => 7/531317 [patent_app_country] => US [patent_app_date] => 1990-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 35 [patent_no_of_words] => 8394 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/071/05071962.pdf [firstpage_image] =>[orig_patent_app_number] => 531317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3584654 [patent_doc_number] => 05516515 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-14 [patent_title] => 'Separation of alpha interferon receptor proteins and antibodies therefor' [patent_app_type] => 1 [patent_app_number] => 7/519357 [patent_app_country] => US [patent_app_date] => 1990-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4833 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/516/05516515.pdf [firstpage_image] =>[orig_patent_app_number] => 519357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2787179 [patent_doc_number] => 05130416 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-07-14 [patent_title] => 'Recombinant DNA clone containing a genomic fragment of PfHRP-II gene from plasmodium falciparum' [patent_app_type] => 1 [patent_app_number] => 7/518299 [patent_app_country] => US [patent_app_date] => 1990-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 2749 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/130/05130416.pdf [firstpage_image] =>[orig_patent_app_number] => 518299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2827975 [patent_doc_number] => 05116948 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-05-26 [patent_title] => 'Preparations of islet amyloid polypeptide (IAPP) and antibodies to IAPP' [patent_app_type] => 1 [patent_app_number] => 7/516329 [patent_app_country] => US [patent_app_date] => 1990-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5359 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/116/05116948.pdf [firstpage_image] =>[orig_patent_app_number] => 516329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3087286 [patent_doc_number] => 05284931 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-02-08 [patent_title] => 'Intercellular adhesion molecules, and their binding ligands' [patent_app_type] => 1 [patent_app_number] => 7/515478 [patent_app_country] => US [patent_app_date] => 1990-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 26 [patent_no_of_words] => 45916 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/284/05284931.pdf [firstpage_image] =>[orig_patent_app_number] => 515478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2693190 [patent_doc_number] => 04990454 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-02-05 [patent_title] => 'YH206 cell line and monoclonal antibody produced by it' [patent_app_type] => 1 [patent_app_number] => 7/463810 [patent_app_country] => US [patent_app_date] => 1990-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5670 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/990/04990454.pdf [firstpage_image] =>[orig_patent_app_number] => 463810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2815309 [patent_doc_number] => 05086164 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-02-04 [patent_title] => 'Novel methods and compositions for treatment of angiogenic diseases' [patent_app_type] => 1 [patent_app_number] => 7/451021 [patent_app_country] => US [patent_app_date] => 1989-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6920 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/086/05086164.pdf [firstpage_image] =>[orig_patent_app_number] => 451021 [rel_patent_id] =>[rel_patent_doc_number] =>)